-

Öz

Objective: Menopause leads to changes in hormonal status, metabolism and lipid profile. The aim of the present study was to determine the influence of menopause and age on lipid profile in women. Methods: This study included 160 postmenopausal and 260 premenopausal healthy women. Serum lipid profile including total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG) and atherogenic index of plasma (AIP) were estimated. Premenopausal women were further arranged in to two different age group of 22-45 years and above 45 years of age. The premenopausal and postmenopausal women were recruited and classified using a comprehensive questionnaire. Results: There were statistically significant increases in TC, LDL-C, TG and AIP but there was no significant difference in HDL-C level between premenopausal and postmenopausal women. Only LDL-C level was significantly increased in premenopausal women above 45 years of age compared with the premenopausal women between 22-45 years of age. Conclusion: Menopause alters lipid profile. Atherogenic index of plasma which is a marker of plasma atherogenicity may be used to asses risk of developing atherosclerosis in postmenopausal women

Anahtar Kelimeler

• Menopause, lipid profile, atherogenic index of plasma

Premenopozal ve postmenopozal kadınlarda lipit profili ve plazma aterojenik indeksinin karşılaştırılması

Öz

Amaç: Menopoz ile birlikte hormonal durum, metabolizma ve lipit profilinde bir takım değişiklikler meydana gelir. Çalışmamızın amacı yaşın ve menopozun lipit profilinde meydana getirdiği değişiklikleri incelemektir. Yöntemler: Çalışmaya sağlıklı 160 postmenopozal ve 260 premenopozal kadın alındı. Tüm olgulara bir anket formu doldurtuldu. Tüm olguların total kolesterol (TK), yüksek yoğunluklu lipoprotein kolesterol (HDL-K), düşük yoğunluklu lipoprotein kolesterol (LDL-K), trigliserid (TG) ve plazma aterojenik indeksi (PAI) değerlendirildi. Premenopozal kadınlar ayrıca 22-45 yaş ile ve 45 yaş üzeri olmak üzere iki gruba ayrıldı. Bulgular: Menopoz sonrası kadınlarda TK, LDL-K, TG ve PAI değerleri anlamlı olarak yüksek bulunurken, HDL-K seviyesinde anlamlı fark saptanmadı. Kırk beş yaş üzeri premenopozal kadınlarda sadece LDL-K seviyesi anlamlı olarak yüksek bulundu. Sonuç: Menopoz lipit profilinde değişiklikler ile birliktedir. Plazma aterojenitesi için bir belirleyici olan PAI, postmenopozal kadınlarda ateroskleroz riski için kullanılabilir. Anahtar kelimeler: Menopoz, lipit profili, plazma aterojenik indeksi.

Anahtar Kelimeler

• Menopoz, lipit profili, plazma aterojenik indeksi

Kaynakça

1. Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and
2. the risk of coronary heart disease in women. N Engl J Med
3. ;316:1105-1110.
4. Hsia J, Barad D, Margolis K, et al. Usefulness of prior hysterectomy
5. as an independent predictor of Framingham
6. risk score (The Women’s Health Initiative). Am J Cardiol
7. ;92:264 -269.
8. Matthan MR, Jalbert SM, Lamon-Fava S, et al. TRL, IDL,

9. and LDL Apolipoprotein B-100 and HDL Apolipoprotein
10. A-I kinetics as a function of age and menopausal status.
11. Arterioscler Thromb Vasc Biol 2005;25:1691-1696.
12. National Cholesterol Education Program (NCEP) Expert Panel
13. on Detection, Evaluation, and Treatment of High Blood
14. Cholesterol in Adults (Adult Treatment Panel III). Third
15. Report of the National Cholesterol Education Program
16. (NCEP) Expert Panel on Detection, Evaluation, and Treatment
17. of High Blood Cholesterol in Adults (Adult Treatment
18. Panel III) final report. Circulation 2002;106:3143-3421.
19. Hokanson JE, Austin MA. Plasma triglyceride level is a risk
20. factor to cardio vascular disease independent of high density
21. lipoprotein cholesterol level: a meta-analysis of population
22. based prospective studies. J Cardiovasc Risk 1996;
23. :213-219.
24. Guerin M, Legoff W, Lassel TS, et al. Proatherogenic role of
25. elevated CE transfer from HDL to VLDL and dense LDL
26. in type 2 diabetics. Arterioscler Thromb Vasc Biol 2001;
27. :282-287.
28. Dobiásová M, Frohlich J. The plasma parameter log (TG/
29. HDL-C) as an atherogenic index: Correlation with lipoprotein
30. particle size and esterification rate in apoB-lipoproteindepleted
31. plasma (FER (HDL)). Clin Biochem 2001;34:583-
32. -
33. Schiller NB, Shah PM, Crawford M, et al. Recommendations
34. for quantitation of the left ventricle by two-dimensional
35. echocardiography. American Society of Echocardiography
36. Committee on Standards, Subcommittee on Quantitation of
37. Two- Dimensional Echocardiograms. J Am Soc Echocardiogr
38. ;2:358-367.
39. Xing D, Nozell S, Chen Y, et al. Estrogen and Mechanisms
40. of Vascular Protection. Arterioscler Thromb Vasc Biol
41. ;29:289-295.
42. Ramos RG, Olden K. The prevalence of metabolic syndrome
43. among US women of childbearing age, Am J Public
44. Health 2008;98:1122-1127.
45. Wu ZY, Wu XK, Zhang YW. Relationship of menopausal
46. status and sex hormones to serum lipids and blood pressure.
47. Int J Epidemiol 1990;19: 297-302.
48. Poehlman ET, Toth MJ, Ades PA, Rosen CJ. Menopauseassociated
49. changes in plasma lipids, insulin-like growth
50. factor I and blood pressure: a longitudinal study. Eur J Clin
51. Invest 1997;27:322-326.
52. Stevenson JC, Crook D, Godsland IF. Influence of age and
53. menopause on serum lipids and lipoproteins in healthy
54. women. Atherosclerosis 1993; 98:83-90.
55. Matthews KA, Meilahn E, Kuller LH, et al. Menopause
56. and risk factors for coronary heart disease. N Engl J Med.
57. ;321:641- 646.
58. Davis CE, Pajak A, Rywik S, et al. Natural menopause and
59. cardiovascular disease risk factors. The Poland and US Collaborative Study on Cardiovascular Disease Epidemiology.
60. Ann Epidemiol 1994;4:445-448.
61. Brown SA, Hutchinson R, Morrisett J, et al. Plasma lipid,
62. lipoprotein cholesterol, and apoprotein distributions in selected
63. US communities. The Atherosclerosis Risk in Communities
64. (ARIC) Study. Arterioscler Thromb 1993;13:1139-1158.
65. Demirovic J, Sprafka JM, Folsom AR, et al. Menopause
66. and serum cholesterol: differences between blacks and
67. whites. The Minnesota Heart Survey. Am J Epidemiol
68. ;136:155-164.
69. Bonithon-Kopp C, Scarabin PY, Darne B, et al. Menopauserelated
70. changes in lipoproteins and some other cardiovascular
71. risk factors. Int J Epidemiol 1990;19:42-48.
72. The writing group for the PEPI trial. Effects of estrogen or
73. estrogen/progestin regimens on heart disease risk factors in
74. postmenopausal women. JAMA 1995;273:199-208.
75. Rosano GM, Fini M. Postmenopausal women and cardiovascular
76. risk: impact of hormone replacement therapy. Cardiol
77. Rev 2002;10:51-60.
78. Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and
79. the risk of coronary heart disease: 10,158 incident cases
80. among 262,525 participants in 29 Western prospective
81. studies. Circulation 2007;115:450-458.
82. Patel A, Barzi F, Jamrozik K, et al. Serum triglycerides as
83. a risk factor for cardiovascular diseases in the Asia-Pacific
84. region. Circulation 2004;110:2678-2686.
85. da Luz PL, Favarato D, Faria-Neto JR Jr, et al. Highratio of
86. triglycerides to HDL-cholesterol predicts extensive coronary
87. disease. Clinics (Sao Paulo) 2008;63:427-432.
88. Gaziano JM, Henne kens CH, O.Donnell CJ, et al. Fasting
89. triglycerides, high density lipoprotein, and risk of myocardial
90. infarction. Circulation 1997;96:2520-2525.
91. Nwagha UI, Ikekpeazu EJ, Ejezie FE, et al. Atherogenic
92. index of plasma as useful predictor of cardiovascular risk
93. among postmenopausal women in Enugu, Nigeria. Afr
94. Health Sci 2010;10:248-252.
95. Söğüt E, Avcı E, Üstüner F, Arıkan E. Serum aterojenite indeksi
96. olarak (TG/HDL-K) oranının değerlendirilmesi. Türk
97. Klinik Biyokimya Derg 2006; 4:1-8.
98. Usoro CAO, Adikwuru CC, Usoro IN, Nsonwu AC. Lipid
99. profile of postmenopausal women in Calabar, Nigeria. Pak
100. J Nutr 2006;5:79-82.
101. Haarbo J, Hassager C, Schlemmer A, Christianson C, Influence
102. of smoking, body fat distribution and alcohol consumption
103. on serum lipids, lipoproteins and apolipoproteins
104. in early postmenopausal women, Atherosclerosis, 1990;84:
105. -244.
106. Onat A. Lipids, Lipoproteins and apolipoproteins among
107. Turks, and impact on coronary heart disease - Invited Review.
108. Anadolu Kardiyol Derg 2004;4:236-245.
109. Kozan Ö, Oğuz A, Abacı A, et al. Prevalence of the metabolic
110. syndrome among Turkish adults. Eur J Clin Nutr
111. ;61:548-553.
112. Açık Y, Sezer E, Sezer H. Frequency and distribution of
113. risk factors for coronary heart disease in the adult population
114. of rural district of Elazıg Turkey. Turk J Med Sci
115. ;29:265-272.
116. Igweh JC, Nwagha IU, Okaro JM. The effects of menopause
117. on the serum lipid profile of normal females of South
118. East Nigeria. Nigerian J Physiol Sci 2005;20:48-53.